Skip to main content
Premium Trial:

Request an Annual Quote

Microchip Biotechnologies Selected for Army SBIR Program

NEW YORK (GenomeWeb News) – The US Army has selected Microchip Biotechnologies to participate in its inaugural Commercialization Pilot Program.
The firm has been developing a biothreat detection system through small business innovation research funding from the Army.
The Army’s new program is focused on identifying SBIR firms with Phase II projects that may “meet high-priority Army requirements,” the company said. However, it did not say how much funding is associated with its participation in the program.
Microchip Biotechnologies said that it is one of 25 firms selected for the program out of an applicant pool of 416 firms.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.